NCT07309146

Brief Summary

This single-center retrospective observational study includes all human milk donors collaborating with the milk bank at České Budějovice Hospital between 2021 and 2025. Using anonymized data extracted from the hospital database, the study will quantify the frequency of donations and the individual and cumulative volume of donated human milk and will assess the impact of key maternal and perinatal factors - including age, BMI, parity, mode of delivery, and timing of donations - on the quantity and quality of donated milk, based on routine biochemical and microbiological parameters.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Jan 2026Sep 2026

First Submitted

Initial submission to the registry

December 4, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 30, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

5 months

First QC Date

December 4, 2025

Last Update Submit

March 16, 2026

Conditions

Keywords

donor human milkhuman milk bankmilk donationmilk volumemilk quality

Outcome Measures

Primary Outcomes (1)

  • Donation intensity

    Donation intensity, defined as the cumulative volume of donated human milk per donor (mL) and the number of donation episodes per donor over the individual donation period within the 5-year study window (2021-2025).

    Assessed at the end of each donor's donation period (from first to last recorded donation), within January 1, 2021 to December 31, 2025.

Secondary Outcomes (1)

  • Quality of donated human milk

    Assessed at the end of each donor's donation period (from first to last recorded donation), within January 1, 2021 to December 31, 2025.

Study Arms (1)

Human Milk Donors

Lactating women who donated human milk to the hospital-based human milk bank at České Budějovice Hospital between 2021 and 2025.

Other: No Interventions

Interventions

Retrospective observational study based on routinely collected clinical and milk bank data; no experimental procedure, treatment, or behavioral intervention is administered.

Human Milk Donors

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Lactating women who donated human milk to the hospital-based human milk bank at České Budějovice Hospital between 2021 and 2025. All donors met the local eligi-bility criteria for milk donation and collaborated with the milk bank during the de-fined period.

You may qualify if:

  • Lactating women who donated human milk to the hospital-based human milk bank at České Budějovice Hospital during the period 2021-2025.
  • Accepted as donors according to local eligibility criteria for human milk donation.
  • At least one recorded donation of human milk with available data on donation date and volume in the milk bank database.
  • Availability of basic maternal and perinatal data (e.g., age, BMI, parity, mode of delivery, timing of donation) in the hospital information sys-tem.

You may not qualify if:

  • Donors with no recorded volume or date of human milk donation in the milk bank database.
  • Records with evident data errors or inconsistencies that cannot be reliably corrected (e.g., implausible dates or volumes).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University

Prague, 10000, Czechia

RECRUITING

Study Officials

  • Pavel Dlouhý, PhD

    Third Faculty of Medicine, Charles University, Prague, Czech Republic

    STUDY DIRECTOR

Central Study Contacts

Jiří Dušek, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 4, 2025

First Posted

December 30, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to the sensitive nature of donor information, absence of explicit consent for external data sharing, and restrictions imposed by local regulations and GDPR.

Locations